Annual EBITDA
-$103.61 M
+$50.17 M+32.63%
December 31, 2024
Summary
- As of March 4, 2025, OM annual EBITDA is -$103.61 million, with the most recent change of +$50.17 million (+32.63%) on December 31, 2024.
- During the last 3 years, OM annual EBITDA has risen by +$21.25 million (+17.02%).
- OM annual EBITDA is now -135.24% below its all-time high of -$44.05 million, reached on December 31, 2018.
Performance
OM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$19.82 M
+$482.00 K+2.37%
December 31, 2024
Summary
- As of March 4, 2025, OM quarterly EBITDA is -$19.82 million, with the most recent change of +$482.00 thousand (+2.37%) on December 31, 2024.
- Over the past year, OM quarterly EBITDA has stayed the same.
- OM quarterly EBITDA is now -39.51% below its all-time high of -$14.21 million, reached on September 30, 2019.
Performance
OM Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$99.29 M
+$13.81 M+12.21%
December 31, 2024
Summary
- As of March 4, 2025, OM TTM EBITDA is -$99.29 million, with the most recent change of +$13.81 million (+12.21%) on December 31, 2024.
- Over the past year, OM TTM EBITDA has stayed the same.
- OM TTM EBITDA is now -598.99% below its all-time high of -$14.21 million, reached on September 30, 2019.
Performance
OM TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
OM EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +32.6% | 0.0% | 0.0% |
| 3 y3 years | +17.0% | +52.1% | +37.2% |
| 5 y5 years | -65.7% | +52.1% | +37.2% |
OM EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +32.7% | at high | +52.8% | at high | +37.3% |
| 5 y | 5-year | -65.7% | +32.7% | -9.8% | +52.8% | -207.8% | +37.3% |
| alltime | all time | -135.2% | +32.7% | -39.5% | +52.8% | -599.0% | +37.3% |
Outset Medical EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$103.61 M(-32.6%) | -$19.82 M(-2.4%) | -$99.29 M(-12.2%) |
| Sep 2024 | - | -$20.30 M(-24.3%) | -$113.10 M(-15.7%) |
| Jun 2024 | - | -$26.82 M(-17.1%) | -$134.22 M(-8.5%) |
| Mar 2024 | - | -$32.35 M(-3.8%) | -$146.69 M(-4.6%) |
| Dec 2023 | -$153.79 M(-0.1%) | -$33.63 M(-18.8%) | -$153.79 M(-2.8%) |
| Sep 2023 | - | -$41.41 M(+5.4%) | -$158.18 M(+1.6%) |
| Jun 2023 | - | -$39.30 M(-0.4%) | -$155.64 M(-1.7%) |
| Mar 2023 | - | -$39.45 M(+3.8%) | -$158.29 M(+2.8%) |
| Dec 2022 | -$153.93 M | -$38.02 M(-2.2%) | -$153.93 M(-0.9%) |
| Sep 2022 | - | -$38.88 M(-7.3%) | -$155.29 M(+7.0%) |
| Jun 2022 | - | -$41.94 M(+19.5%) | -$145.14 M(+10.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$35.09 M(-10.9%) | -$131.63 M(+5.4%) |
| Dec 2021 | -$124.86 M(+8.2%) | -$39.38 M(+37.1%) | -$124.86 M(+8.4%) |
| Sep 2021 | - | -$28.73 M(+1.0%) | -$115.16 M(-9.9%) |
| Jun 2021 | - | -$28.43 M(+0.4%) | -$127.76 M(+2.7%) |
| Mar 2021 | - | -$28.32 M(-4.6%) | -$124.41 M(+7.8%) |
| Dec 2020 | -$115.44 M(+84.6%) | -$29.68 M(-28.2%) | -$115.44 M(+11.2%) |
| Sep 2020 | - | -$41.32 M(+64.7%) | -$103.81 M(+35.4%) |
| Jun 2020 | - | -$25.09 M(+29.7%) | -$76.69 M(+48.6%) |
| Mar 2020 | - | -$19.34 M(+7.1%) | -$51.60 M(+60.0%) |
| Dec 2019 | -$62.54 M(+42.0%) | -$18.05 M(+27.1%) | -$32.26 M(+127.1%) |
| Sep 2019 | - | -$14.21 M | -$14.21 M |
| Dec 2018 | -$44.05 M | - | - |
FAQ
- What is Outset Medical annual EBITDA?
- What is the all time high annual EBITDA for Outset Medical?
- What is Outset Medical annual EBITDA year-on-year change?
- What is Outset Medical quarterly EBITDA?
- What is the all time high quarterly EBITDA for Outset Medical?
- What is Outset Medical quarterly EBITDA year-on-year change?
- What is Outset Medical TTM EBITDA?
- What is the all time high TTM EBITDA for Outset Medical?
- What is Outset Medical TTM EBITDA year-on-year change?
What is Outset Medical annual EBITDA?
The current annual EBITDA of OM is -$103.61 M
What is the all time high annual EBITDA for Outset Medical?
Outset Medical all-time high annual EBITDA is -$44.05 M
What is Outset Medical annual EBITDA year-on-year change?
Over the past year, OM annual EBITDA has changed by +$50.17 M (+32.63%)
What is Outset Medical quarterly EBITDA?
The current quarterly EBITDA of OM is -$19.82 M
What is the all time high quarterly EBITDA for Outset Medical?
Outset Medical all-time high quarterly EBITDA is -$14.21 M
What is Outset Medical quarterly EBITDA year-on-year change?
Over the past year, OM quarterly EBITDA has changed by $0.00 (0.00%)
What is Outset Medical TTM EBITDA?
The current TTM EBITDA of OM is -$99.29 M
What is the all time high TTM EBITDA for Outset Medical?
Outset Medical all-time high TTM EBITDA is -$14.21 M
What is Outset Medical TTM EBITDA year-on-year change?
Over the past year, OM TTM EBITDA has changed by $0.00 (0.00%)